RedHill Biopharma (RDHL) Posts Q1 Loss of 5c/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. CSX
7. LRCX
8. MRK
9. LVS
10. SAP

Go back to RedHill Biopharma (RDHL) Posts Q1 Loss of 5c/Share

RedHill Biopharma Reports Results for the First Quarter of 2015

April 30, 2015 7:02 AM EDT

Key Highlights Include:

Strong cash position of approximately $32.5 million at the end of the first quarter of 2015, following the closing of the Company's first public offering in the U.S. including participation by leading institutional healthcare investors Key milestones achieved in the first quarter of 2015 included the acquisition of the exclusive worldwide license to ABC294640, a Phase II-stage, proprietary, first-in-class, orally-administered sphingosine kinase-2 (SK2) inhibitor from Apogee Biotechnology Corp., targeting multiple oncology and inflammatory-GI diseases Milestones expected in the second quarter of 2015... More